ADHD treatment: Strategies for optimizing adherence

Consultant

Volumn 51, Issue 11, 2011, Pages 824-833

  Charach, Alice ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EVIDENCE BASED PRACTICE; FEMALE; HEALTH BELIEF MODEL; HUMAN; LOW DRUG DOSE; MALE; MEDICAL DECISION MAKING; PARENTAL ATTITUDE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 84856386869     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jadad AR, Booker L, Gauld M, et al. The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses. Can J Psychiatry. 1999;44:1025-1035. (Pubitemid 30062402)
2. Barbaresi WJ, Katusic SK, Colligan RC, et al. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28:274-287. (Pubitemid 47256030)
3. Biederman J, Monuteaux MC, Spencer T, et al. Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics. 2009;124:71-78.
4. Katusic SK, Barbaresi WJ, Colligan RC, et al. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol. 2005;15:764-776. (Pubitemid 41567148)
5. Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005;159:572-578. (Pubitemid 40973481)
6. Miller AR, Lalonde CE, McGrail KM. Children's persistence with methylphenidate therapy: a population-based study. Can J Psychiatry. 2004;49:761-768. (Pubitemid 40094949)
7. Barbaresi WJ, Katusic SK, Colligan RC, et al. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006;27:1-10. (Pubitemid 44315107)
8. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033-1044.
9. Greenhill LL, Pliszka S, Dulcan MK, et al. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2001;40:1352-1355.
10. Wolraich ML, Wibbelsman CJ, Brown TE, et al. Attention-deficit/ hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications. Pediatrics. 2005;115:1734-1746. (Pubitemid 43843185)
11. dosReis S, Mychailyszyn MP, Evans-Lacko SE, et al. The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child. J Child Adolesc Psychopharmacol. 2009;19:377-383.
12. Charach A, Skyba A, Cook L, Antle BJ. Using stimulant medication for children with ADHD: what do parents say? A brief report. J Can Acad Child Adolesc Psychiatry. 2006;15:75-83. (Pubitemid 43810951)
13. Charach A, Gajaria A. Improving psychostimulant adherence in children with ADHD. Expert Rev Neurother. 2008;8:1563-1571.
14. Ajzen I, Fishbein M. Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ: Prentice-Hall, 1980.
15. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10-24.
16. Bull C, Whelan T. Parental schemata in the management of children with attention deficit-hyperactivity disorder. Qual Health Res. 2006;16:664-678.
17. Hansen DL, Hansen EH. Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication. Qual Health Res. 2006;16:1267-1285. (Pubitemid 44541921)
18. Reach G. Role of habit in adherence to medical treatment. Diabet Med. 2005;22:415-420. (Pubitemid 40516240)
19. Gau SS, Chen SJ, Chou WJ, et al. National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/ hyperactivity disorder in Taiwan. J Clin Psychiatry. 2008;69:131-140. (Pubitemid 351282007)
20. Klassen AF, Miller A, Fine S. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics. 2004;114:e541-e547. (Pubitemid 41655750)
21. Charach A, Volpe T, Boydell KM, Gearing RE. A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry. 2008;16:126-135. (Pubitemid 351549822)
22. dosReis S, Zito JM, Safer DJ, et al. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 2003;24:155-162. (Pubitemid 36939990)
23. Gau SSF, Shen HY, Chou MC, et al. Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol. 2006;16:286-297. (Pubitemid 43902425)
24. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47:1102-1114.
25. Pescosolido BA. Beyond rational choice: the social dynamices of how people seek help. Am J Sociology 1992;97:1096-1138.
26. Pescosolido BA, Perry BL, Martin JK, et al. Stigmatizing attitudes and beliefs about treatment and psychiatric medications for children with mental illness. Psychiatr Serv. 2007;58:613-618. (Pubitemid 46841881)
27. Bussing R, Gary FA. Practice guidelines and parental ADHD treatment evaluations: friends or foes? Harv Rev Psychiatry. 2001;9:223-233. (Pubitemid 32906582)
28. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86:184-192. (Pubitemid 20238848)
29. Johnston C, Seipp C, Hommersen P, et al. Treatment choices and experiences in attention deficit and hyperactivity disorder: relations to parents'beliefs and attributions. Child Care Health Develop. 2005;31:669-677. (Pubitemid 41535911)
30. Leslie LK, Plemmons D, Monn AR, Palinkas LA. Investigating ADHD treatment trajectories: listening to families' stories about medication use. J Dev Behav Pediatr. 2007;28:179-188. (Pubitemid 46944227)
31. Swanson JM, Hinshaw SP, Arnold LE, et al. Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry. 2007;46:1003-1014. (Pubitemid 47220684)
32. Bussing R, Gary FA, Mills TL, Garvan CW. Parental explanatory models of ADHD: gender and cultural variations. Soc Psychiatry Psychiatr Epidemiol. 2003;38:563-575. (Pubitemid 37265292)
33. Bussing R, Zima BT, Gary FA, Garvan CW. Barriers to detection, help-seeking, and service use for children with ADHD symptoms. J Behav Health Serv Res. 2003;30:176-189. (Pubitemid 36397440)
34. Jensen PS, Arnold LE, Swanson JM, et al. 3-Year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry. 2007;46:989-1002. (Pubitemid 47220683)